HRP20110258T1 - Postupci za dobivanje heksahidrofuro[2,3-b]furan-3-ola - Google Patents

Postupci za dobivanje heksahidrofuro[2,3-b]furan-3-ola Download PDF

Info

Publication number
HRP20110258T1
HRP20110258T1 HR20110258T HRP20110258T HRP20110258T1 HR P20110258 T1 HRP20110258 T1 HR P20110258T1 HR 20110258 T HR20110258 T HR 20110258T HR P20110258 T HRP20110258 T HR P20110258T HR P20110258 T1 HRP20110258 T1 HR P20110258T1
Authority
HR
Croatia
Prior art keywords
formula
compound
alkyl
image
arylalkyl
Prior art date
Application number
HR20110258T
Other languages
English (en)
Croatian (hr)
Inventor
Fran�ois Emmanuel Lemaire S�bastien
Horvath Andras
Albert Alex Aelterman Wim
Joachim Landewald Rammeloo Thomas
Original Assignee
Tibotec Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37692659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110258(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals filed Critical Tibotec Pharmaceuticals
Publication of HRP20110258T1 publication Critical patent/HRP20110258T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HR20110258T 2006-11-09 2011-04-11 Postupci za dobivanje heksahidrofuro[2,3-b]furan-3-ola HRP20110258T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06123752 2006-11-09
PCT/EP2007/062119 WO2008055970A2 (fr) 2006-11-09 2007-11-09 Procédés pour la préparation du hexahydrofuro[2,3-b]furan-3-ol

Publications (1)

Publication Number Publication Date
HRP20110258T1 true HRP20110258T1 (hr) 2011-05-31

Family

ID=37692659

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110258T HRP20110258T1 (hr) 2006-11-09 2011-04-11 Postupci za dobivanje heksahidrofuro[2,3-b]furan-3-ola

Country Status (22)

Country Link
US (1) US8153829B2 (fr)
EP (1) EP2089371B1 (fr)
JP (1) JP5491862B2 (fr)
CN (2) CN101541775B (fr)
AT (1) ATE497499T1 (fr)
AU (1) AU2007316562B2 (fr)
BR (1) BRPI0718706B8 (fr)
CA (1) CA2669014C (fr)
CY (1) CY1111407T1 (fr)
DE (1) DE602007012365D1 (fr)
DK (1) DK2089371T3 (fr)
ES (1) ES2359949T3 (fr)
HR (1) HRP20110258T1 (fr)
IL (1) IL198270A (fr)
ME (1) ME01232B (fr)
MX (1) MX2009004957A (fr)
PL (1) PL2089371T3 (fr)
PT (1) PT2089371E (fr)
RS (1) RS51675B (fr)
RU (1) RU2464266C2 (fr)
SI (1) SI2089371T1 (fr)
WO (1) WO2008055970A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010075887A1 (fr) * 2008-12-30 2010-07-08 Oxyrane (Uk) Limited Procédés et intermédiaires utiles dans la synthèse d'hexahydrofuro[2,3-b]furan-3-ol
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
WO2011051978A2 (fr) 2009-10-30 2011-05-05 Lupin Limited Nouveau procédé de préparation de darunavir et d'éthanolate de darunavir de taille particulaire fine
PT2513116E (pt) 2009-12-16 2015-10-14 Hetero Research Foundation Polimorfos de darunavir
MX2012008627A (es) 2010-01-28 2012-09-21 Mapi Pharma Ltd Proceso para la preparacion de darunavir e intermedios de darunavir.
US8853430B2 (en) 2010-05-20 2014-10-07 Hetero Research Foundation Crystalline hydrochloride salt of darunavir
CN102617586B (zh) * 2011-01-26 2016-04-06 浙江九洲药业股份有限公司 地瑞那韦中间体的制备方法
ES2755087T3 (es) 2012-08-22 2020-04-21 Merck Sharp & Dohme Derivados de benzimidazol hexahidrofuro[3,2-b]furano útiles como activadores de proteína cinasa activada por AMP
CN103864813B (zh) * 2012-12-18 2017-02-22 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
CN103896886A (zh) * 2012-12-31 2014-07-02 上海迪赛诺化学制药有限公司 一种达鲁那韦中间体及其制备方法和应用
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
CN107344944B (zh) * 2016-05-07 2021-03-05 成都博腾药业有限公司 一种制备地瑞那韦中间体的方法
CN112300186B (zh) * 2019-08-01 2024-04-30 浙江九洲药业股份有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (fr) 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino-sulfonamides aptes a etre utilises comme inhibiteurs de protease retrovirale
EP0749421B1 (fr) * 1994-03-07 1999-09-15 Vertex Pharmaceuticals Incorporated Derives de sulfamides en tant qu'inhibiteurs de protease d'aspartyle
US5929284A (en) 1995-02-03 1999-07-27 Kaneka Corporation Processes for producing α-halo ketones, α-halohydrins and epoxides
US5753660A (en) 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5856531A (en) * 1996-10-21 1999-01-05 Eastman Chemical Company Preparation of 3-methytetra-hydrofuran from 2,3-dihydrofuran
US5990313A (en) * 1996-10-21 1999-11-23 Eastman Chemical Company Preparation of 3-alkyltetrahydrofurans
EP0932607A2 (fr) * 1996-10-21 1999-08-04 Eastman Chemical Company Preparation de 3-alkyltetrahydrofuranes
NZ508855A (en) 1998-06-19 2003-10-31 Vertex Pharma Sulfonamide inhibitors of HIV aspartyl protease
ES2362404T5 (es) 1998-06-23 2015-11-25 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Ensayo de aptitud y métodos para reducir la resistencia del VIH a terapia
WO1999067254A2 (fr) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Inhibiteurs de protease retrovirale resistant a l'action de plusieurs medicaments et procedes associes
US6278002B1 (en) 1998-08-25 2001-08-21 Kaneka Corporation Process for the preparation of (2r,3s)-3-amino-1,2-oxirane
CA2325919C (fr) 1999-01-29 2009-07-21 Kaneka Corporation Procede de preparation de derives de threo-1,2-epoxy-3-amino-4-phenylbutane
SI1159278T1 (sl) 1999-02-12 2006-06-30 Vertex Pharma Inhibitorji aspartil proteaze
AR031520A1 (es) 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
KR100708221B1 (ko) 1999-08-31 2007-04-17 아지노모토 가부시키가이샤 에폭사이드 결정의 제조방법
WO2001025240A1 (fr) 1999-10-06 2001-04-12 Tibotec Pharmaceuticals Ltd. HEXAHYDROFURO'2,3-B! FURAN-3-YL-N- {3'(1,3-BENZODIOXOL-5-YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL}CARBAMATE EN TANT QU'INHIBITEUR DE PROTEASE RETROVIRALE
WO2002060905A2 (fr) 2000-10-24 2002-08-08 Glaxo Group Ltd Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih
US6764545B2 (en) 2000-12-12 2004-07-20 Ajinomoto Co., Inc. Production method of epoxide crystal
ES2338538T3 (es) * 2001-09-10 2010-05-10 Tibotec Pharmaceuticals Metodo para la preparacion de hexahidrofuro(2,3-b)furan-3-ol.
JP2005510467A (ja) 2001-09-20 2005-04-21 スミスクライン ビーチャム コーポレーション プロテアーゼ阻害剤中間体の調製方法
PT2767539T (pt) * 2002-05-16 2017-08-28 Janssen Sciences Ireland Uc Formas pseudopolimórficas de um inibidor de protease de hiv
DK1532127T3 (da) * 2002-06-27 2007-02-05 Smithkline Beecham Corp Fremstilling af stereoisomerer af (3alfa,3alfa/beta,6alfa/beta)hexahydrofuro(2,3-b)furan-3-ol
WO2004033462A2 (fr) 2002-10-09 2004-04-22 The Board Of Trustees Of The University Of Illinois Procede de preparation de (3r, 3as, 6ar) -3- hydroxyhexahydrofuro [2, 3-b] furane et de composes apparentes
WO2004060895A1 (fr) * 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited Procede de production d'un derive de d'hexahydrofuranol, intermediaire de celui-ci et procede de production correspondant
ATE433982T1 (de) * 2003-12-23 2009-07-15 Tibotec Pharm Ltd Verfahren zur herstellung von (1s,2r)-3-ää(4- aminophenyl)sulfonylü(isobutyl)aminoü-1-benzyl- - hydroxypropylcarbamidsäure-(3r,3as,6ar)- hexahydrofuroä2,3-büfuran-3-ylester
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法

Also Published As

Publication number Publication date
AU2007316562A1 (en) 2008-05-15
CN101541775B (zh) 2011-12-28
AU2007316562B2 (en) 2013-02-21
DE602007012365D1 (de) 2011-03-17
ME01232B (fr) 2013-06-20
ES2359949T3 (es) 2011-05-30
CN102432621A (zh) 2012-05-02
CN101541775A (zh) 2009-09-23
US8153829B2 (en) 2012-04-10
US20100094028A1 (en) 2010-04-15
DK2089371T3 (da) 2011-05-16
IL198270A0 (en) 2009-12-24
PT2089371E (pt) 2011-04-18
CN102432621B (zh) 2016-02-17
RU2009121792A (ru) 2010-12-20
EP2089371A2 (fr) 2009-08-19
CY1111407T1 (el) 2015-08-05
ATE497499T1 (de) 2011-02-15
RU2464266C2 (ru) 2012-10-20
MX2009004957A (es) 2009-05-19
PL2089371T3 (pl) 2011-06-30
RS51675B (en) 2011-10-31
JP5491862B2 (ja) 2014-05-14
BRPI0718706B1 (pt) 2021-03-23
CA2669014A1 (fr) 2008-05-15
JP2010509290A (ja) 2010-03-25
CA2669014C (fr) 2016-01-26
SI2089371T1 (sl) 2011-05-31
BRPI0718706A2 (pt) 2014-01-07
WO2008055970A2 (fr) 2008-05-15
EP2089371B1 (fr) 2011-02-02
WO2008055970A3 (fr) 2008-06-26
BRPI0718706B8 (pt) 2021-05-25
IL198270A (en) 2014-02-27

Similar Documents

Publication Publication Date Title
HRP20110258T1 (hr) Postupci za dobivanje heksahidrofuro[2,3-b]furan-3-ola
Chanda et al. Recent progress in organocatalytic asymmetric domino transformations
HRP20201480T1 (hr) Derivati indolinona i postupak za njihovu proizvodnju
Gao et al. Azaphilones: chemistry and biology
IL289834B1 (en) Conversion of tricyclic compounds as FGFR inhibitors
HRP20150305T1 (hr) Postupak za pripravu intermedijera spojeva korisnih kao modulatori opioid receptora
HRP20080510T3 (en) Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
WO2016179184A2 (fr) Synthèse énantiosélective d'intermédiaires de produits naturels d'hétéroyohimbines
Zhao et al. Enantioselective synthesis of enol lactones from tandem Michael addition/lactonization catalyzed by a chiral squaramide catalyst
Bennasar et al. Synthetic Efforts toward Akuammiline Alkaloids from Tetracyclic 6, 7-Seco Derivatives
Sakhuja et al. Ytterbium triflate catalyzed synthesis of heterocycles
RU2010140442A (ru) Трициклические производные пиридина, лекарственные средства, содержащие такие соединения, их применение и способ их получения
EP2105793A3 (fr) Composition durcissable verte, filtre de couleur, et son procédé de production
HRP20221061T1 (hr) Postupak za pripremu sintetičkih intermedijera za pripremu tetrahidrokinolinskih derivata
Ahmed et al. The reactivity of 8-hydroxyquinoline and its derivatives toward α-cyanocinnamonitriles and ethyl α-cyanocinnamates: Synthesis, reactions, and applications of 4H-pyrano [3, 2-h] quinoline derivatives
WO2008052088A8 (fr) Dérivés de chromane, synthèse de ceux-ci et leurs intermédiaires
Saito et al. Nine new norlabdane diterpenoids from the leaves of Austroeupatorium inulifolium
Kidwai et al. An investigatory study of antibacterial activity of functionalized spirooxindoles
Mohammadi Ziarani et al. Synthesis of dihydropyrido [2, 3-d] pyrimidine derivatives in the presence of sulfonic acid functionalized SBA-15 and the study of their antimicrobial activities
EP0494209A4 (en) Cyclic peroxyacetal lactone, lactol and ether compounds
Masuda et al. 7-Hydroxycoumarin derivatives from the juice oil of Citrus hassaku
LT6024B (lt) Nauji fotochrominiai junginiai, jų gamybos būdas ir tarpiniai junginiai jiems gauti
ES2692656T3 (es) Preparación diastereoselectiva de los compuestos de biciclo[2.2.2]octan-2-ona
Alcaide et al. Stereoselective entry to bicyclic β-lactams via free radical cyclization of 2-azetidinone-tethered bromohomoallylic alcohols
HRP20120686T1 (hr) Postupak priprave intermedijera tricikličkih spojeva